Literature DB >> 1553250

Detection of contamination with antineoplastic agents in a hospital pharmacy department.

P J Sessink1, R B Anzion, P H Van den Broek, R P Bos.   

Abstract

The contamination with fluorouracil, cyclophosphamide and methotrexate was studied in a hospital pharmacy department where these drugs were prepared. In the preparation room, air samples were taken before and during preparation of the drugs. Methotrexate was detected in one sample which was collected during preparation (0.3 micrograms/m3). Spot samples were taken in the vertical laminar airflow safety hood before and after preparation of the drugs and after cleaning of the hood. Contamination of the laminar airflow hood was: cyclophosphamide: 1-160 ng/cm2; fluorouracil: 10-62 ng/cm2 and methotrexate: 2-633 ng/cm2. Spot samples from the floor in front of and beneath the laminar airflow hood showed contamination with especially fluorouracil (48-236 micrograms/m2). The gloves used during preparation of the drugs were contaminated mainly with fluorouracil (5-980 ng/cm2). Urine samples from two workers involved in the preparation of the drugs were analysed for unmetabolized cyclophosphamide; it was not detected. Although no uptake of cyclophosphamide was established, it is shown that the methods for measurement of cyclophosphamide, fluorouracil and methotrexate in the preparation room are applicable for the control of occupational exposure to these drugs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1553250     DOI: 10.1007/bf01989220

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  44 in total

1.  Sister chromatid exchanges and chromosomal aberrations in lymphocytes of nurses handling cytostatic agents.

Authors:  S Benhamou; J Pot-Deprun; H Sancho-Garnier; I Chouroulinkov
Journal:  Int J Cancer       Date:  1988-03-15       Impact factor: 7.396

2.  The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects.

Authors:  H T Mouridsen; O Faber; L Skovsted
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-08

3.  Comparison of three assays for genetic effects of antineoplastic drugs on cancer patients and their nurses.

Authors:  A Krepinsky; D W Bryant; L Davison; B Young; J Heddle; D R McCalla; G Douglas; K Michalko
Journal:  Environ Mol Mutagen       Date:  1990       Impact factor: 3.216

4.  The efficiency of protective gloves used in the handling of cytotoxic drugs.

Authors:  M L Slevin; L M Ang; A Johnston; P Turner
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  Exposure of pharmacy personnel to mutagenic antineoplastic drugs.

Authors:  T V Nguyen; J C Theiss; T S Matney
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

6.  Chromosome analyses of nurses handling cytostatic agents.

Authors:  H Waksvik; O Klepp; A Brøgger
Journal:  Cancer Treat Rep       Date:  1981 Jul-Aug

7.  Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs.

Authors:  H Norppa; M Sorsa; H Vainio; P Gröhn; E Heinonen; L Holsti; E Nordman
Journal:  Scand J Work Environ Health       Date:  1980-12       Impact factor: 5.024

8.  Limitations of the salmonella/mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs.

Authors:  U Friederich; F Molko; V Hofmann; D Scossa; D Hann; F E Würgler; H J Senn
Journal:  Eur J Cancer Clin Oncol       Date:  1986-05

9.  Handling of cytostatic drugs and urine mutagenesis.

Authors:  D Poyen; M P De Méo; A Botta; J Gouvernet; G Duménil
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

10.  Risk of handling injectable antineoplastic agents.

Authors:  R W Anderson; W H Puckett; W J Dana; T V Nguyen; J C Theiss; T S Matney
Journal:  Am J Hosp Pharm       Date:  1982-11
View more
  21 in total

Review 1.  Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.

Authors:  P J Sessink; R P Bos
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

2.  A probabilistic assessment of the impact of interventions on oncology nurses' exposure to antineoplastic agents.

Authors:  T Meijster; W Fransman; J van Hemmen; H Kromhout; D Heederik; E Tielemans
Journal:  Occup Environ Med       Date:  2006-03-21       Impact factor: 4.402

3.  Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process.

Authors:  Luci A Power; Paul J M Sessink; Kathy Gesy; Flay Charbonneau
Journal:  Hosp Pharm       Date:  2014-04

4.  Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.

Authors:  Paul J M Sessink; Thomas H Connor; James A Jorgenson; Timothy G Tyler
Journal:  J Oncol Pharm Pract       Date:  2010-02-15       Impact factor: 1.809

5.  Pilot Evaluation of Dermal Contamination by Antineoplastic Drugs among Hospital Pharmacy Personnel.

Authors:  Chun-Yip Hon; George Astrakianakis; Quinn Danyluk; Winnie Chu
Journal:  Can J Hosp Pharm       Date:  2011-09

6.  Development of a new method for sampling and monitoring oncology staff exposed to cyclophosphamide drug.

Authors:  Davood Panahi; Mansour Azari; Mohammad Esmaeil Akbari; Rezvan Zendehdel; Hamid Reza Mirzaei; Hossein Hatami; Yadollah Mehrabi
Journal:  Environ Monit Assess       Date:  2016-03-22       Impact factor: 2.513

7.  Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendations.

Authors:  Thomas H Connor; Matthew D Zock; Amy H Snow
Journal:  J Occup Environ Hyg       Date:  2016-09       Impact factor: 2.155

8.  Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.

Authors:  Maria Hedmer; Peter Höglund; Eva Cavallin-Ståhl; Maria Albin; Bo A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2007-06-20       Impact factor: 3.015

9.  Occupational exposure to cytotoxic drugs in two UK oncology wards.

Authors:  E Ziegler; Howard J Mason; P J Baxter
Journal:  Occup Environ Med       Date:  2002-09       Impact factor: 4.402

10.  Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.

Authors:  Paul J M Sessink; Jason Trahan; Joseph W Coyne
Journal:  Hosp Pharm       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.